The enzyme dopa decarboxylase:
A) inhibits the conversion of dopamine to levodopa.
B) inhibits the conversion of levodopa to dopamine.
C) converts dopamine to levodopa.
D) converts levodopa to dopamine.
Correct Answer:
Verified
Q20: The clinical syndrome of parkinsonism includes all
Q21: _ is used to inhibit peripheral catechol-o-methyltransferase
Q22: The most undesirable side effects of treatment
Q23: The new dopamine receptor agonists are _
Q24: Inhibition of _ in the liver
Q26: _ is the mainstay of therapy for
Q27: Undesirable side effects are minimized by combining
Q28: Traditional drug treatments for parkinsonism target the
Q29: The enzyme _ converts dopa into
Q30: Selegiline ameliorates symptoms of parkinsonism through a
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents